GlassScriptIonis Pharmaceuticals, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.3Mgeneral payments (2019-2025)
$29Kresearch payments (2019-2025)
2,934clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Joseph Loscalzo | Boston, MA | Cardiovascular Disease | $903,928.88 |
| Spencer Berthelsen | Sugar Land, TX | Internal Medicine | $891,083.14 |
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $111,241.59 |
| Benjamin Philpott | Rocky Mount, VA | Family Medicine | $64,160.00 |
| Joseph Gleeson | San Diego, CA | Neurology With Special Qualifications In Child Neurology | $60,025.00 |
| Seth Baum | Boca Raton, FL | Cardiovascular Disease | $55,751.88 |
| Jon Ruckle | Tacoma, WA | Internal Medicine | $54,705.00 |
| H James Wedner | Saint Louis, MO | Allergy & Immunology (Internal Medicine) | $33,617.79 |
| Autumn Burnette | Washington, DC | Allergy & Immunology (Internal Medicine) | $30,996.14 |
| Michael Rafii | La Jolla, CA | Neurology (Psychiatry & Neurology) | $25,920.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.